PDCD1 and neoplasm: Furthermore, a combination of the pBI-11 DNA and tissue-antigen HPV vaccine (TA-HPV) boosts vaccination with the PD-1 antibody blockade significantly improved the control of TC-1 tumours and extended the survival in the animal model [550].